3 New Strong Buy Ratings from Top-Rated Analysts: 10/23/2026

By Jessie Moore, Stock Researcher and Writer
October 23, 2026 6:18 AM UTC
3 New Strong Buy Ratings from Top-Rated Analysts: 10/23/2026

Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

  • Indivior Pharmaceuticals Inc (INDV): A growing profit margin plus a special dividend declared
  • Diodes Incorporated (DIOD): Analysts see over 50% upside ahead 
  • Nvent Electric (NVT): AMD cooling partnership puts it inside AI buildout (big upside energy)

P.S. Want more Strong Buy-rated stocks? Here are more of our top picks RN.

 


A note from our sponsors...

This Tiny Sub–$1 Gold-Silver Royalty Stock Is Ready to Run

Record revenue. Producing gold and silver assets. The biggest transaction in company history. And shares still largely undiscovered below $1. This tiny royalty firm puts its capital to work in carefully selected mining projects in exchange for a share of the gold and silver produced. Now that compounding machine is shifting into a much higher gear – backed by a powerful deal-flow advantage and some of the smartest money in the sector.

The window to get in early may be closing fast.


1. Indivior Pharmaceuticals (NASDAQ: INDV)

This company focuses on opioid dependence treatment, and demand is growing. With its flagship Sublocade product driving robust growth and the company recently declaring a special cash dividend, INDV is demonstrating both strong commercial execution and shareholder-friendly capital allocation ahead of its Q3 earnings report.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $34.77 — get current quote

Max 1-year forecast: $43.00

Why we're watching:

  • INDV has limited, but overall bullish, coverage among the analysts we track, with 1 Strong Buy recommendation. See all recommendations here
  • For example, Barclays researcher Glen Santangelo (a top 25% rated analyst) recently maintained his Strong Buy recommendation with a price target representing nearly 25% upside potential from current levels.
  • Industry ranking context: INDV is currently the #5 highest-rated stock in the Pharmaceutical industry, which has an Industry Rating of B.
  • Zen Ratings highlights: INDV earns an overall A rating, which amounts to a Strong Buy recommendation. This rating places the stock among the top-performing equities we track, validated by a comprehensive 115-factor analytical framework.
  • Component Grades: INDV demonstrates exceptional quality with As for both Financials and Value, reflecting the company's impressive 35.6% profit margin and attractive valuation, complemented by a strong B for Safety that underscores the defensive nature of its specialized addiction treatment franchise. See all 7 Component Grades here

2. Diodes Incorporated (NASDAQ: DIOD)

This global semiconductor company recently completed an acquisition that has strengthened the company's automotive product portfolio, positioning DIOD to capitalize on the secular shift toward vehicle electrification and advanced driver assistance systems.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $88.34 — get current quote

Max 1-year forecast: $133.00

Why we're watching:

  • DIOD has limited, but overall bullish, coverage among the analysts we track, with 1 Strong Buy recommendation. See all recommendations here
  • For example, Truist Securities researcher William Stein (a top 1% rated analyst) recently maintained his Strong Buy rating with a price target representing nearly 60% upside potential from current levels.
  • Industry ranking context: DIOD is currently the #6 highest-rated stock in the Semiconductor industry, which has an Industry Rating of A.
  • Zen Ratings highlights: DIOD earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
  • Component Grades: DIOD earns solid Bs for Value and Sentiment, reflecting a price-to-book of 2.01 against a semiconductor industry average above 11 and a PEG ratio of 0.54, alongside analyst confidence in the automotive semiconductor growth story.  See all 7 Component Grades here

3. Nvent Electric (NYSE: NVT)

This company is riding a powerful wave of AI data center infrastructure demand. Recent collaborations with AMD on advanced cooling solutions for AI rackscale systems position the company at the center of the AI infrastructure buildout, with upcoming Q3 earnings expected to showcase continued momentum in this high-growth vertical.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $143.97 — get current quote

Max 1-year forecast: $228.00

Why we're watching:

  • NVT has strong, bullish coverage among the analysts we track, with 6 Strong Buy, 5 Buy, and 1 Hold recommendations. See all recommendations here
  • For example, JP Morgan researcher Julian Mitchell (a top 2% rated analyst) recently reinstated his Strong Buy recommendation with a price target representing about 20% upside potential from current levels.
  • That’s good, but some price targets suggest much greater growth potential. For instance, Citigroup researcher Vladimir Bystricky (a top 16% rated analyst) maintained his Strong Buy with a price target representing greater than 60% upside potential from current levels.
  • Industry ranking context: NVT is currently the #5 highest-rated stock in the Electrical Equipment & Parts industry.
  • Zen Ratings highlights: NVT earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all 4,600+ stocks tracked based on a rigorous 115-factor fundamental review.
  • Component Grades: NVT excels with an A for Sentiment, signaling strong analyst conviction and market optimism around the company's AI infrastructure opportunity, while maintaining solid Bs for Financials and Growth that support the bullish thesis. See all 7 Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.